ArticleCurrent drug discovery technologies2024

QSAR Studies and Scaffold Optimization of Predicted Novel ACC 2 Inhibitors to Treat Metabolic Syndrome.

Kirtika Madan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.